Adverum Biotechnologies
ADVM
ADVM
77 hedge funds and large institutions have $70M invested in Adverum Biotechnologies in 2022 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 11 increasing their positions, 27 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
77
Holders Change
-15
Holders Change %
-16.3%
% of All Funds
1.3%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
16
Increased
11
Reduced
27
Closed
29
Calls
$1.9M
Puts
$13K
Net Calls
+$1.89M
Net Calls Change
-$259K
Top Buyers
| 1 |
1
Morgan Stanley
New York
|
$8.84M |
| 2 |
RCM
2
RA Capital Management
Boston,
Massachusetts
|
$2.07M |
| 3 |
3
Millennium Management
New York
|
$1.25M |
| 4 |
NM
4
Newtyn Management
New York
|
$1.24M |
| 5 |
5
Renaissance Technologies
New York
|
$1.31M |
